Off 10% after company update cited some slight delay in clinical trials sign-up procedure and therefore results delayed till Q4 instead of Q3 2004.
IMO presented a buying opportunity as the impatient passed their shares to the patient
Topped up @ 80. R/B
correction
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)